Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient

Best Practice and Research: Clinical Anaesthesiology

Volumn 28, Issue 1, 2014, Pages 91-101

  Vadivelu, Nalini ^a   Mitra, Sukanya ^b   Kaye, Alan David ^c   Urman, Richard D ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

buprenorphine; drug addiction; drug dependence; methadone maintenance; opioid dependence; perioperative analgesia; sub anesthetic ketamine infusion

Indexed keywords

ALPRAZOLAM; AMPHETAMINE; BUPRENORPHINE; CANNABIS; CENTRAL DEPRESSANT AGENT; CENTRAL STIMULANT AGENT; COCAINE; DIAZEPAM; KETAMINE; LOCAL ANESTHETIC AGENT; LYSERGIDE; METHADONE; OPIATE DERIVATIVE; PHENCYCLIDINE; PSYCHEDELIC AGENT; ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ANXIETY; DRUG DEPENDENCE; DRUG MISUSE; HEMODYNAMIC MONITORING; HEROIN DEPENDENCE; HUMAN; LOCAL ANESTHESIA; METHADONE TREATMENT; OPIATE ADDICTION; PEROPERATIVE CARE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW; URINALYSIS; COMPLICATION; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PERIOPERATIVE PERIOD; PROCEDURES; SUBSTANCE-RELATED DISORDERS;

ANALGESIA; ANALGESICS, OPIOID; ANESTHETICS; HUMANS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PERIOPERATIVE CARE; SUBSTANCE-RELATED DISORDERS;

EID: 84922219686     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2014.02.003     Document Type: Review

References (48)

1. S.R. Savage Addiction in the treatment of pain: significance, recognition, and management J Pain Symptom Manage 8 5 1993 265 278
2. F. Cavaliere, E. Iacobone, and M. Gorgoglione et al. Anesthesiologic preoperative evaluation of drug addicted patient Minerva Anestesiol 71 6 2005 367 371
3. D. Brookoff, E.A. Campbell, and L.M. Shaw The underreporting of cocaine-related trauma: drug abuse warning network reports vs hospital toxicology tests Am J Public Health 83 3 1993 369 371
4. L. Feinstein, and K. Schmidt Cocaine users present unique anesthetic challenges: part 1 Anesthesiol News 36 2 2010 8 9
5. A.D. Kaye, and J.L. Weinkauf The cocaine addicted patient E. Bryson, E. Frost, Perioperative addiction chapter 5 2012 Springer New York 95 110
6. K.K. Chen Pharmacology of methadone and related compunds Ann New York Acad Sci 51 1 1948 83 97
7. M.J. Krantz, J. Martin, and B. Stimmel et al. QTc interval screening in methadone treatment Ann Intern Med 150 6 2009 387 395
8. E.E. Codd, R.P. Shank, and J.J. Schupsky et al. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception J Pharmacol Exp Ther 274 3 1995 1263 1270
9. A. Ferrari, C.P. Coccia, and A. Bertolini et al. Methadone-metabolism, pharmacokinetics and interactions Pharmacol Res 50 6 2004 551 559
10. K.L. Preston, D.H. Epstein, and D. Davoudzadeh et al. Methadone and metabolite urine concentrations in patients maintained on methadone J Anal Toxicol 27 6 2003 332 341
11. M.L. Sotgiu, M. Valente, and R. Storchi et al. Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain Pharmacol Res 60 4 2009 284 290
12. A. Gottschalk, M.E. Durieux, and E.C. Nemergut Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery Anesth Analg 112 1 2011 218 223
13. A. Umbricht, D.R. Hoover, and M.J. Tucker et al. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection Drug Alcohol Depend 69 3 2003 263 272
14. J.R. Hughes, W.K. Bickel, and S.T. Higgins Buprenorphine for pain relief in a patient with drug abuse Am J Drug Alcohol Abuse 17 4 1991 451 455
15. V. Modesto-Lowe, D. Brooks, and N. Petry Methadone deaths: risk factors in pain and addicted populations J Gen Intern Med 25 4 2010 305 309
16. J. Ballantyne, and K. LaForge Opioid dependence and addiction during opioid treatment of chronic pain Pain 129 3 2007 235 255
17. J. Højsted, and P. Sjøgren Addiction to opioids in chronic pain patients: a literature review Eur J Pain 11 5 2007 490 518
18. M.A. Jarvis, S. Wu-Pong, and J.S. Kniseley et al. Alterations in methadone metabolism during late pregnancy J Addict Dis 18 4 1999 51 61
19. A. Doehring, N. Hentig, and J. Graff et al. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution Pharmacogenet Genomics 19 6 2009 407 414
20. C.H. Chen, S.C. Wang, and H.H. Tsou et al. Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients Pharmacogenomics 12 10 2011 1397 1406
21. F. Fonseca, R. de la Torre, and L. Díaz et al. Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements response PLoS One 6 5 2011 e19527
22. J.K. Coller, D.T. Barratt, and K. Dahlen et al. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals Clin Pharmacol Ther 80 6 2006 682 690
23. J.C. Maxwell, and E.F. McCance-Katz Indicators of buprenorphine and methadone use and abuse: what do we know? Am J Addict 19 1 2010 73 88
24. C.A. Kornick, M.J. Kilborn, and J. Santiago-Palma et al. QTc interval prolongation associated with intravenous methadone Pain 105 3 2003 499 506
25. M. Gil, M. Sala, and I. Anguera et al. QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone Am J Cardiol 92 8 2003 995 997
26. M.J. Krantz, L. Lewkowiez, and H. Hays et al. Torsade de pointes associated with very-high-dose methadone Ann Intern Med 137 6 2002 501 504
27. V. Piguet, J. Desmeules, and G. Ehret et al. QT interval prolongation in patients on methadone with concomitant drugs J Clin Psychopharmacol 24 4 2004 446 448
28. M.J. Krantz, S.B. Rowan, and P.S. Mehler Cocaine-related torsade de pointes in a methadone maintenance patient J Addict Dis 24 1 2005 53 60
29. B.M. Kapur, J.R. Hutson, and T. Chibber et al. Methadone: a review of drug-drug and pathophysiological interactions Crit Rev Clin Lab Sci 48 4 2011 171 195
30. M. Kotlyar, L.H. Brauer, and T.S. Tracy et al. Inhibition of CYP2D6 activity by bupropion J Clin Psychopharmacol 25 3 2005 226 229
31. S.H. Preskorn, D.J. Greenblatt, and D. Flockhart et al. Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers J Clin Psychopharmacol 27 1 2007 28 34
32. M. Davoli, A.M. Bargagli, and C.A. Perucci et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study Addiction 102 12 2007 1954 1959
33. R.C. Heel, R.N. Brogden, and T.M. Speight et al. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy Drugs 17 2 1979 81 110
34. A. Elkader, and B. Sproule Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence Clin Pharmacokinet 44 7 2005 661 680
35. W.R. Lange, P.J. Fudala, and E.M. Dax et al. Safety and side-effects of buprenorphine in the clinical management of heroin addiction Drug Alcohol Depend 26 1 1990 19 28
36. J. Kakko, L. Grönbladh, and K.D. Svanborg et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial Am J Psychiatry 164 5 2007 797 803
37. J. Kakko, K.D. Svanborg, and M.J. Kreek et al. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial Lancet 361 9358 2003 662 668
38. H. Malinoff, R. Barkin, and G. Wilson Sublingual buprenorphine is effective in the treatment of chronic pain syndrome Am J Ther 12 5 2005 379 384
39. H.A. Heit, and D.L. Gourlay Urine drug testing in pain medicine J Pain Symptom Manage 27 3 2004 260 267
40. K. Budd, and B.J. Collett Old dog-new (ma)trix Br J Anaesth 90 6 2003 722 724
41. D.P. Alford, P. Compton, and J.H. Samet Acute pain management for patients receiving maintenance methadone or buprenorphine therapy Ann Intern Med 144 2 2006 127 134
42. D. Roberts, and M. Meyer-Witting High-dose buprenorphine: perioperative precautions and management strategies Anaesth Intensive Care 33 1 2005 17 25
43. A. Risbo, B. Chraemmer Jørgensen, and P. Kolby et al. Sublingual buprenorphine for premedication and postoperative pain relief in orthopaedic surgery Acta Anaesthesiol Scand 29 2 1985 180 182
44. J. Hayakawa, Y. Usuda, and Y. Okutsu et al. Periodic sublingual buprenorphine for pain relief after upper abdominal surgery Masui 38 4 1989 493 497
45. R.E. Bullingham, H.J. McQuay, and D. Dwyer et al. Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis Br J Clin Pharmacol 12 2 1981 117 122
46. R.E. Johnson, P.J. Fudala, and R. Payne Buprenorphine: considerations for pain management J Pain Symptom Manage 29 3 2005 297 326
47. C. Hand, J. Sear, and J. Uppington et al. Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites Br J Anaesth 64 3 1990 276 282
48. R.J. Summerfield, M.C. Allen, and R.A. Moore et al. Buprenorphine in end stage renal failure Anaesthesia 40 9 1985 914